Form 4: Quanterix Corp Director Elliott Jeffrey Thomas Reports Acquisition of Restricted Stock Units and Stock Options

Director Elliott Jeffrey Thomas reports the acquisition of restricted stock units and stock options in Quanterix Corp.

Summary

• On August 19, 2024, Director Elliott Jeffrey Thomas acquired 11,985 shares of common stock through the vesting of restricted stock units at a price of $0.00.
• These restricted stock units vest in three equal installments on August 19, 2025, August 19, 2026, and August 19, 2027.
• Thomas also acquired options to purchase 25,908 shares of common stock at an exercise price of $13.35 on the same date.
• These options vest as to one-third of the shares on August 19, 2025, with the remaining two-thirds vesting monthly over the subsequent two years.
• Following these transactions, Thomas directly owns 11,985 shares of common stock and 25,908 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports routine stock transactions. The acquisition of shares by a director could be seen as a slightly positive signal, but it's primarily a procedural disclosure.

Positives

• The acquisition of restricted stock units and stock options by a director may signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the biotech industry where equity compensation is frequently used.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are a common form of compensation for directors and executives in publicly traded companies, particularly in the biotech sector.
• Vesting schedules of three years are fairly standard for restricted stock units.
• Option terms of 10 years are also typical.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's long-term success.

Key Dates